Lan T, Zhu Y, Zhong W, Tan Q, et al. Evaluating the efficacy and safety of bladder-sparing regimen with Disitamab Vedotin combined with Toripalimab and pelvic lymph node dissection in muscle-invasive bladder cancer patients: study protocol of a multicenter single-arm phase II trial. BMC Cancer 2025;25:868.
PMID: 40361038